Sign In
NewsRadar

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

   


Scil Technology Files Patent on Coating Technology for Implants


The technology claimed in this application allows coating of medical implants like screws, nails, stents etc. with active pharmaceutical compounds, especially recombinant proteins. The process, which retains the native structure and activity of a protein when directly coated onto the surface of a metal implant is easily transferable to large scale aseptic manufacturing.
The Company plans to use this technology in the first instance for the commercial, cost effective manufacturing of regenerative, growth factor activated dental implants. These will be developed for patients who have a risk for lower dental implant success rates because of their poor jaw bone quality caused by insufficient oral hygiene, heavy smoking, osteoporosis or insufficiently treated diabetes associated with high blood sugar level.
In addition to the activated dental implants the technology could also be applied to orthopaedic implants for various applications.
Dr Irina Staatz-Granzer, Managing Director of Scil Technology, commented:
“Scil Technology has pioneered this unique coating technology, which will allow us to develop regenerative, activated implants that actually facilitate the osseointegration of the respective implants.”
– ends –

About Scil Technology GmbH
Scil Technology is a private biopharmaceutical development company focused on dental and orthopaedic tissue regeneration with a particular emphasis on bone and cartilage repair. The Company’s lead therapeutic candidates are based on recombinant, highly specific human growth factors. These are combined with biodegradable biomaterials to generate local application forms. Scil Technology’s pipeline for dentistry includes products that are targeted at periodontal disease, dental implantology and maxillofacial surgery. Orthopaedic products are developed for spinal fusion, traumatic lesions of bone and cartilage tissue and osteoarthritis. Scil Technology has emerged from the Scil Group and is located in the biotechnology cluster in Martinsried, Germany.
For more information please visit: http://www.scil.com



Publisher Contact Information:

Scil Technology GmbH
+49 (0)89 85651824
i.staatz@scil.com

Company profile of Scil Technology GmbH
Past press releases of Scil Technology GmbH.

Data


26,129
Tech investments
From our Online Data Service
16,883
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Sep 13N/AEnergy related
Sep 13€12.6MConsumer electronics
Sep 12€39.0MBiopharmaceuticals
Sep 12N/AKnowledge management
Sep 12€2.3MInternet commerce
Sep 12€2.1MInternet services
Sep 12€4.0MMedical devices

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises £1m in seed funding to build tech-enabled home ...





About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.